No Data
Xilinmen Furniture (603008.SH): The company did not implement share buybacks in February.
On February 28, Gelonghui reported that Xilinmen Furniture (603008.SH) announced that by February 2025, the company had not implemented any share repurchase. As of February 28, 2025, the company has cumulatively repurchased 7,550,400 shares through centralized bidding, accounting for 1.99% of the company's total share capital. The highest Fill Price was 20.60 yuan/share, the lowest Fill Price was 14.83 yuan/share, and the total amount of funds paid was 129.9924 million yuan (excluding transaction costs).
Is Xilinmen Furniture Co.,Ltd (SHSE:603008) Trading At A 33% Discount?
Xilinmen Furniture (603008.SH): has repurchased a total of 1.99% of its shares.
On February 5, Gelonghui reported that Xilinmen Furniture (603008.SH) announced that as of January 31, 2025, the company had repurchased a total of 7,550,400 shares through a centralized bidding trading method, accounting for 1.99% of the company's total share capital, with the highest Fill Price at 20.60 yuan per share and the lowest Fill Price at 14.83 yuan per share. The total amount of funds paid is 129.9924 million yuan (excluding transaction fees).
There's No Escaping Xilinmen Furniture Co.,Ltd's (SHSE:603008) Muted Earnings
Dizhe Pharmaceutical "Xilinmen Furniture": Innovative products successfully enter medical insurance and Refinancing has been approved.
Shanghai, December 11, 2024 /PR Newswire/ -- On December 11, 2024, Di Zhe Pharmaceutical announced that its Private Placement plan on the Star has been approved by the Shanghai Stock Exchange. This marks the first approval for refinancing for an unprofitable company since the release of the China Securities Regulatory Commission's "Eight Measures to Deepen the Reform of the Star, Serving Technological Innovation and the Development of New Productive Forces." On November 28, the National Healthcare Security Administration held a press conference to introduce the results of the 2024 adjustments to the national basic Medical, work-related injury insurance, maternity insurance Pharmaceutical catalog for two innovative source products under Di Zhe Pharmaceutical.
Xilinmen Furniture Co.,Ltd's (SHSE:603008) Largest Shareholders Are Retail Investors Who Were Rewarded as Market Cap Surged CN¥803m Last Week
The Returns On Capital At Xilinmen FurnitureLtd (SHSE:603008) Don't Inspire Confidence
